Analysis of Debt
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Total Debt (Carrying Amount)
Abbott Laboratories, balance sheet: debt
US$ in millions
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The carrying amount of total long-term debt exhibited a declining trend over the five-year period. Initial values were relatively high, but a consistent reduction is apparent through the end of the observed period.
- Overall Trend
- Total long-term debt, including current maturities, decreased from US$18,050 million in 2021 to US$12,929 million in 2025. This represents a cumulative reduction of approximately 28.4% over the five years.
- Current Portion of Long-Term Debt
- The current portion of long-term debt demonstrated considerable fluctuation. It increased significantly from US$754 million in 2021 to US$2,251 million in 2022, before decreasing to US$1,080 million in 2023. A subsequent increase to US$1,500 million occurred in 2024, followed by a substantial rise to US$3,033 million in 2025. This suggests a shifting pattern in short-term debt obligations.
- Long-Term Debt (Excluding Current Portion)
- Long-term debt, excluding current maturities, generally decreased throughout the period. It fell from US$17,296 million in 2021 to US$9,896 million in 2025. The largest decrease occurred between 2021 and 2022, with a reduction of US$2,774 million. Subsequent declines were more moderate, indicating a sustained effort to reduce long-term obligations.
The combined effect of these changes indicates a strategy focused on reducing overall debt, with some variability in the timing of short-term versus long-term debt management. The increasing current portion of long-term debt in the final year suggests a potential restructuring of debt maturities or increased reliance on short-term financing.
Total Debt (Fair Value)
| Dec 31, 2025 | |
|---|---|
| Selected Financial Data (US$ in millions) | |
| Total long-term debt, including current maturities (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (reporting date: 2025-12-31).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt:
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| Total | |||
Based on: 10-K (reporting date: 2025-12-31).
1 US$ in millions
2 Weighted-average interest rate = 100 × ÷ =